Investigative Urology - Results from #6880

Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: Correlation with Gleason score - Abstract March 10, 2011

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer - Abstract March 9, 2011

Contemporary role of prostate cancer gene 3 in the management of prostate cancer - Abstract March 9, 2011

Activation of the androgen receptor by intratumoral bioconversion of androstanediol to dihydrotestosterone in prostate cancer - Abstract March 9, 2011

Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial) - Abstract March 8, 2011

Amplification and overexpression of vinculin are associated with increased tumour cell proliferation and progression in advanced prostate cancer - Abstract March 7, 2011

Endoscopic resection of bladder cancer in patients receiving double platelet antiaggregant therapy - Abstract March 7, 2011

The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer - Abstract March 7, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Prostate cancer outcomes and polymorphism in LHRH and LH receptors and SHBG - Session Highlights March 7, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Identification of gene copy number and whole-genome methylation changes associated with lethal metastatic castration-resistant prostate cancer (CRPC) - Session Highlights March 7, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Tumor response and adaptation to CYP17 inhibition in prostate cancer: Induction of steroidogenesis and androgen receptor splice variants - Session Highlights March 4, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Effect of dual inhibition of the Src and insulin-like growth factor-1 receptor (IGF-1R) pathways on antitumor effects in prostate cancer (PCa) - Session Highlights March 4, 2011

Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells - Abstract March 3, 2011

Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer - Abstract March 3, 2011

GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer - Abstract March 2, 2011

Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: A case-control study - Abstract March 2, 2011

Developing an effective gene therapy for prostate cancer: New technologies with potential to translate from the laboratory into the clinic - Abstract March 2, 2011

GU Cancers Symposium 2011: ASCO ASTRO SUO - Use of variation in sex steroid methyl transferases to predict efficacy of androgen-deprivation therapy (ADT) in advanced prostate cancer - Session Highlights March 2, 2011

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer - Abstract March 1, 2011

Phosphatidylinositol 3-kinase inhibitor LY294002 suppresses proliferation and sensitizes doxorubicin chemotherapy in bladder cancer cells - Abstract March 1, 2011

Page 345 of 346